Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma

LAG-3 is one of the common tumor immune checkpoints. LAG-3 can inhibit the activation and proliferation of T cells, and can also suppress immunity by regulating other immune-related cell functions. FGL1 was recently discovered to be the main ligand of immune checkpoint LAG-3 and play a critical role...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Qing Yan, Hao-Ming Lin, Ke Zhu, Yi Cao, Xiao-Lin Xu, Zi-Yu Zhou, Lei-bo Xu, Chao Liu, Rui Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-02-01
coleção:	Frontiers in Oncology
Assuntos:	circulating tumor cells FGL1 hepatocellular carcinoma (HCC) immunotherapy clinical application
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2022.810269/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!